Novartis, Others Can’t Stop Generic Tobramycin Suit

An Illinois federal judge denied an attempt by Novartis Pharmaceuticals and others to dismiss a suit they brought against Akorn over a patent for cystic fibrosis medication, finding that Akorn should still get a chance to have the patent declared invalid.
Law360